NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  



NIH Main


NIH Research News


Funded News

  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
  Additional Resources
  NIH Home Page

About NIH

  NIH Health Information
  Pub Med
  More News and Events Sources
  NIH News and Events, Special Interest
  RSS Feed RSS Feed
  Back to EurekAlert!


Department of Health and Human Services

News from the National Institutes of Health

Funded News

Key: Meeting M      Journal J      Funder F

Showing releases 3101-3125 out of 3799.

<< < 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 > >>

Public Release: 8-Oct-2014
Academic Medicine
Online intervention tool for physician trainees may improve care of substance users
Online learning interventions and small group debriefings can improve medical residents' attitudes and communication skills toward patients with substance use disorders, and may result in improved care for these patients, according to a new study from the Perelman School of Medicine at the University of Pennsylvania and Drexel University College of Medicine published online in Academic Medicine.
NIH/National Institute on Drug Abuse

Contact: Anna Duerr
University of Pennsylvania School of Medicine

Public Release: 8-Oct-2014
Researchers capture images of elusive protein HIV uses to infect cells
HIV is adept at eluding immune system responses because the protein it uses to infect cells is constantly changing. Now a team of researchers including scientists from Yale have stripped the cloak from this master of disguise, providing a high resolution image of this surface spike protein and monitoring how it constantly changes its shape, information that suggests new ways to attack the virus through drugs and vaccines.
National Institutes of Health, The Cancer Research Institute, China Scholarships Council, International AIDS Vaccine Initiative, Bill & Melinda Gates Foundation, United States Agency for International Development

Contact: Jim Shelton
Yale University

Public Release: 8-Oct-2014
New England Journal of Medicine
Patient's dramatic response and resistance to cancer drug traced to unsuspected mutations
Patients with lethal thyroid cancer experienced response for 18 months on clinical trial of everolimus. Sequencing of the tumor before and after trials yielded information on why tumor responded to and eventually resisted treatment, identifying mutations that may help guide treatment of patients with cancers with similar mutations.
Next Generation Fund at the Broad Institute, Novartis Pharmaceuticals, Starr Cancer Consortium, NIH/National Cancer Institute

Contact: Teresa Herbert
Dana-Farber Cancer Institute

Public Release: 8-Oct-2014
Journal of Clinical Investigation
Novel protein in heart muscle linked to cardiac short-circuiting and sudden cardiac deaths
Cardiovascular scientists at NYU Langone Medical Center have identified in mouse models a protein known as Pcp4 as a regulator of the heart's rhythm. Additionally, when the Pcp4 gene is disrupted, it can cause ventricular arrhythmias. Results from this animal study were released online Oct. 8 in the peer-reviewed publication, The Journal of Clinical Investigation.
National Institutes of Health

Contact: Allison Clair
NYU Langone Medical Center / New York University School of Medicine

Public Release: 8-Oct-2014
New England Journal of Medicine
New gene therapy for 'bubble boy' disease appears effective, safe, study in NEJM reports
A new form of gene therapy for boys with X-linked severe combined immunodeficiency syndrome, a life-threatening condition also known as 'bubble boy' disease, appears to be effective and safe, a collaborative international research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions report. Early data suggest the therapy may avoid the late-developing leukemia seen in a quarter of SCID-X1 patients in pioneering gene therapy trials in Europe more than a decade ago.
National Institutes of Health, Harvard Catalyst, Boston Children's Hospital, others

Contact: Irene Sege
Dana-Farber Cancer Institute

Public Release: 7-Oct-2014
Five UCSF researchers win NIH high-risk, high-reward grants
UC San Francisco researchers received five awards announced this week by the National Institutes of Health for high-risk, high-reward scientific research projects.
National Institutes of Health

Contact: Jeffrey Norris
University of California - San Francisco

Public Release: 7-Oct-2014
Mark Andermann, Ph.D., receives NIH New Innovator Award to study cravings and hunger
Beth Israel Deaconess Medical Center neuroendocrinologist Mark Andermann, Ph.D., has been awarded a prestigious Director's New Innovator Award from the National Institute of Diabetes and Digestive and Kidney Disorders and the NIH Common Fund to study how hunger drives cravings.
National Institutes of Health, NIH/National Institute of Diabetes and Digestive and Kidney Disorders

Contact: Bonnie Prescott
Beth Israel Deaconess Medical Center

Public Release: 7-Oct-2014
Cell Reports
Survival molecule helps cancer cells hide from the immune system
A new study shows that the molecule nuclear factor kappa B helps tumors grow by inhibiting the body's ability to detect cancer cells. The molecule suppresses immune surveillance mechanisms, including the production of cells that inhibit immune responses. The research suggests that cancer immune therapy might be improved if combined with NF-kB inhibitors, and it provides new details about interactions between cancer cells and non-cancer cells that assist tumor growth.
NIH/National Cancer Institute

Contact: Darrell E. Ward
Ohio State University Wexner Medical Center

Public Release: 7-Oct-2014
Cancer Epidemiology, Biomarkers & Prevention
New at-risk group identified for gastrointestinal stromal tumors
Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors, which occur primarily in the lining of the stomach and small intestine. One key finding: patients of Asian descent, who have not previously been identified as an at-risk population, are 1.5 times more likely than other patient groups to be diagnosed with this type of tumor.
National Institutes of Health, Gastrointestinal Stromal Tumor Research Fund

Contact: Jackie Carr
University of California - San Diego

Public Release: 7-Oct-2014
H7N9 flu vaccine study shows adjuvant is essential for effective immune response
A clinical trial of an experimental H7N9 avian influenza vaccine found an immune response believed to be protective in 59 percent of study participants who received two injections of inactivated vaccine at the lowest dosage tested when mixed with an adjuvant. Without the adjuvant, there was a minimal immune response.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Holly Korschun
Emory Health Sciences

Public Release: 7-Oct-2014
Journal of Substance Abuse Treatment
State policies can influence access to heroin treatment, study finds
Abuse of heroin and prescription opioid drugs is growing rapidly, creating a need for more treatment options. A new study finds that state policies can influence the number of physicians licensed to prescribe buprenorphine, a drug that can treat addiction to heroin and other opioids in outpatient settings.
NIH/National Institute of Drug Abuse

Contact: Warren Robak
RAND Corporation

Public Release: 7-Oct-2014
Cognitive Development
Toddlers regulate behavior to avoid making adults angry
Researchers at the University of Washington have found that children as young as 15 months can detect anger when watching other people's social interactions and then use that emotional information to guide their own behavior.
National Institutes of Health

Contact: Molly McElroy
University of Washington

Public Release: 7-Oct-2014
Study: Stroke-fighting drug offers potential treatment for traumatic brain injury
The only drug currently approved for treatment of stroke's crippling effects shows promise, when administered as a nasal spray, to help heal similar damage in less severe forms of traumatic brain injury. In the first examination of its kind, researchers found in animal studies that the brain's limited ability to repair itself after trauma can be enhanced when treated with the drug tPA, or tissue plasminogen activator.
NIH/National Institute of Neurological Disorders and Stroke, NIH/National Institute on Aging

Contact: Dwight Angell
Henry Ford Health System

Public Release: 7-Oct-2014
Journal of Neuroscience
Working memory hinders learning in schizophrenia
Trouble with working memory makes a distinct contribution to the difficulty people with schizophrenia sometimes have in learning, according to a new study. The researchers employed a specially designed experiment and computational models to distinguish the roles of working memory and reinforcement learning.
NIH/National Institute of Mental Health

Contact: David Orenstein
Brown University

Public Release: 7-Oct-2014
Researchers find link between tobacco use and viral infection that causes oral cancers
Johns Hopkins scientists have shown a strong association between tobacco use or exposure and infection with oral human papillomavirus type 16, the sexually transmitted virus responsible for mouth and throat cancers worldwide. The numbers of such cancers have increased 225 percent in the United States over the past two decades.
NIH/National Institute of Dental and Craniofacial Research, Milton J. Dance Jr. Head and Neck Center at Greater Baltimore Medical Center, Merck

Contact: Vanessa Wasta
Johns Hopkins Medicine

Public Release: 7-Oct-2014
Cell Metabolism
Live and let-7: MicroRNA plays surprising role in cell survival
Researchers at the University of California, San Diego School of Medicine have identified a microRNA molecule as a surprisingly crucial player in managing cell survival and growth. The findings, published in the Oct. 7 issue of Cell Metabolism, underscore the emerging recognition that non-coding RNAs -- small molecules that are not translated into working proteins -- help regulate basic cellular processes and may be key to developing new drugs and therapies.
National Institutes of Health, Portuguese Foundation for Science and Technology

Contact: Scott LaFee
University of California - San Diego

Public Release: 7-Oct-2014
PLOS Biology
How female flies know when to say 'yes'
A fundamental question in neurobiology is how animals, including humans, make decisions. A new study publishing in PLOS Biology on Oct. 7 reveals how fruit fly females make a very important decision: to either accept or reject male courtship. This decision appears to be generated by a very small number of excitatory neurons that use acetylcholine as their neurotransmitter located in three brain regions. This study provides the framework to understand how decisions are generated.
National Institutes of Health, National Science Foundation

Contact: PLOS Biology

Public Release: 7-Oct-2014
JAMA findings reveal vaccine approach to fight pandemic bird flu
A Saint Louis University study in JAMA reveals a vaccination strategy researchers can continue to study to protect people from bird flu that has the potential to become epidemic.
NIH/National Insitite of Allergy and Infectious Diseases

Contact: Nancy Solomon
Saint Louis University

Public Release: 7-Oct-2014
Nature Communications
A new pathway discovered regulating autoimmune diseases
Researchers found that NAD+, a natural molecule found in living cells, plants and food protects against autoimmune diseases by altering the immune response and turning 'destructive' cells into 'protective' cells.
National Institutes of Health, Slim Foundation

Contact: Marjorie Montemayor-Quellenberg
Brigham and Women's Hospital

Public Release: 6-Oct-2014
Journal of Allergy & Clinical Immunology
Asthma risk varies with ethnic ancestry among Latinos, UCSF team finds
Native-American ancestry is associated with a lower asthma risk, but African ancestry is associated with a higher risk, according to the largest-ever study of how genetic variation influences asthma risk in Latinos, in whom both African- and Native-American ancestry is common.
National Institutes of Health

Contact: Jeffrey Norris
University of California - San Francisco

Public Release: 6-Oct-2014
Annals of Internal Medicine
Program to reduce hospital readmissions doesn't have impact
Researchers at UC San Francisco have found that a nurse-led intervention program designed to reduce readmissions among ethnically and linguistically diverse older patients did not improve 30-day hospital readmission rates.
The Gordon and Betty Moore Foundation, Agency for Healthcare Research and Quality, National Institutes of Health

Contact: Scott Maier
University of California - San Francisco

Public Release: 6-Oct-2014
Case Western Reserve scientist captures prestigious NIH director's New Innovator Award
For the second consecutive year, a Case Western Reserve University School of Medicine researcher has landed one of the year's much-coveted Director's New Innovator Awards from the National Institutes of Health. Principal investigator Rong Xu, Ph.D., assistant professor of medical informatics, will receive $2,377,000 for five years, starting immediately, to initiate computational analysis of thousands of drugs and their effects.
National Institutes of Health

Contact: Jeannette Spalding
Case Western Reserve University

Public Release: 6-Oct-2014
Nature Communications
High-sugar diet no problem for genetic mutants
Scientists find a genetic pathway for circumventing the weight gain that accompanies a high-sugar diet.
National Institutes of Health, Ellison Medical Foundation, American Federation of Aging Research

Contact: Robert Perkins
University of Southern California

Public Release: 6-Oct-2014
Guang Yue, Ph.D., of Kessler Foundation awarded NIH grant for cancer rehabilitation research
Guang Yue, Ph.D., of Kessler Foundation has been awarded an NIH grant for $1,962,767 to study the impact of high-effort training on the muscle weakness that impairs quality life for individuals with cancer. Dr. Yue is the Foundation's director of Human Performance & Engineering Research. This five-year RO1 grant will enable him to pursue his preliminary findings that indicate that high-effort combined with low-intensity muscle exercise training can significantly improve muscle strength in women with breast cancer.
National Institutes of Health

Contact: Carolann Murphy
Kessler Foundation

Public Release: 6-Oct-2014
UCI stem cell scientist wins coveted NIH New Innovator Award
UC Irvine scientist Weian Zhao will receive a prestigious National Institutes of Health Director's New Innovator Award to further his efforts to create stem cell-based detection methods and treatments for cancer.
National Institutes of Health

Contact: Tom Vasich
University of California - Irvine

Showing releases 3101-3125 out of 3799.

<< < 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 > >>


Copyright ©2015 by AAAS, the science society.